Keyphrases
Myocardial Infarction
100%
Adverse Cardiac Remodeling
100%
Apolipoprotein A-I (ApoA-I)
100%
Monocyte Activation
100%
L-4F
100%
Left Ventricular Remodeling
50%
Inflammatory Monocytes
33%
Post-myocardial Infarction
33%
Inflammatory Macrophages
33%
Excessive Inflammation
33%
Mouse Model
16%
Gene Expression
16%
Macrophages
16%
Inflammation
16%
Heart Failure
16%
Left Ventricular Dysfunction
16%
Beneficial Effects
16%
Alleviation
16%
Prolonged Inflammation
16%
Inflammatory Genes
16%
Reperfused Myocardial Infarction
16%
Glycolysis-related Genes
16%
Mimetic Peptide
16%
Infarct Expansion
16%
Therapeutic Adjuncts
16%
Immune Cell Profile
16%
Anti-atherogenic Properties
16%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Heart Ventricle Remodeling
100%
Apolipoprotein A1
100%
Inflammation
37%
Mouse Model
12%
Infarction
12%
Apolipoprotein A
12%
Heart Failure
12%
Anti-Inflammatory Drug
12%
Immunology and Microbiology
Macrophage
100%
Monocyte
100%
Mouse Model
33%
Gene Expression
33%
Immunocompetent Cell
33%